BCIDP study materials
BCIDP study resources

BCIDP study plan

BCIDP · Give each week a clear focus.

8 weeks · About 7 hours per week

Week 1

Microbiology, Pathophysiology, and Immunology of Infectious Diseases & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents

  • Map the weight of each domain against exam percentage and allocate remaining study hours accordingly

  • Explain the structure, resistance mechanisms, and virulence factors of the major bacterial pathogens by organism class

  • Describe key fungal, viral, and mycobacterial pathogen biology and how each shapes drug selection

  • Define pharmacodynamic indices (time above MIC, Cmax/MIC, AUC/MIC) and classify major antimicrobial classes as concentration- or time-dependent killers

  • Build a one-page reference table linking each major drug class to its PK/PD driver and target attainment threshold

Your checkpoint

A two-page organism-to-drug-class summary sheet plus a PK/PD driver table covering at least 12 antimicrobial classes

Week 2

Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents & Microbiology, Pathophysiology, and Immunology of Infectious Diseases

  • Derive the pharmacokinetic parameters (Vd, clearance, half-life, bioavailability) that govern empiric dosing decisions

  • Compare absorption, distribution, and elimination differences among beta-lactams, glycopeptides, aminoglycosides, fluoroquinolones, and azoles

  • Explain host immune defenses and how immunocompromise alters expected drug response and prophylaxis choices

  • Predict how renal or hepatic impairment, obesity, and protein binding shift dosing for at least five agents

  • Work through 15 PK calculation problems (loading dose, maintenance dose, AUC estimation) without reference

Your checkpoint

Completed 15-item PK calculation worksheet with at least 90% accuracy and a written explanation for each missed item

Week 3

Clinical Management of Infectious Diseases Syndromes & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents

  • Select empiric regimens for community-acquired pneumonia, urinary tract infection, and intra-abdominal infection using local resistance patterns

  • Justify de-escalation and definitive therapy choices based on culture and susceptibility results

  • Explain the pharmacology and spectrum of beta-lactam/beta-lactamase inhibitor combinations and compare their roles

  • Differentiate the clinical presentation and management of sepsis, endocarditis, and meningitis

  • Identify the PK/PD rationale for extended-infusion beta-lactams and when to recommend them

Your checkpoint

Three written syndrome-based case analyses (pneumonia, bacteremia/endocarditis, intra-abdominal) each with empiric, definitive, and de-escalation rationale

Week 4

Antimicrobial Stewardship and Infection Prevention & Clinical Management of Infectious Diseases Syndromes

  • Design a stewardship intervention (prospective audit and feedback, preauthorization, or syndrome-specific pathway) and describe its metrics

  • Explain how to build and interpret an antibiogram and apply it to empiric therapy decisions

  • Describe core infection prevention practices including hand hygiene, isolation precautions, and device-related bundle elements

  • Apply Clostridioides difficile and multidrug-resistant organism prevention strategies to a hospital scenario

  • Outline the diagnostic workup for skin and soft tissue infection, osteomyelitis, and prosthetic joint infection

Your checkpoint

A one-page stewardship business case with a proposed intervention, target metric, and 90-day evaluation plan

Week 5

Clinical Management of Infectious Diseases Syndromes & Diagnostic Testing, Susceptibility Interpretation, and Therapeutic Drug Monitoring

  • Manage fungal infections (candidemia, invasive aspergillosis, cryptococcal disease) with appropriate antifungal selection and monitoring

  • Select and sequence antiretroviral and opportunistic infection therapy for a patient with advanced HIV

  • Interpret minimum inhibitory concentration, breakpoints, and susceptibility categories for common organisms

  • Explain when and how to order therapeutic drug monitoring for vancomycin, aminoglycosides, and voriconazole

  • Differentiate colonization from true infection when interpreting respiratory and wound cultures

Your checkpoint

A completed susceptibility interpretation exercise (10 isolates) with a written TDM plan for two of the agents involved

Week 6

Special Populations and Antimicrobial Dosing Considerations & Patient Safety, Adverse Effects, Drug Interactions, and Regulatory/Professional Practice

  • Adjust antimicrobial dosing for patients on renal replacement therapy, extracorporeal membrane oxygenation, and in critical illness with altered volume of distribution

  • Develop dosing and monitoring plans for pregnancy, neonates, and older adults with polypharmacy

  • Identify clinically significant antimicrobial drug interactions and describe the monitoring required for each

  • Recognize and manage serious adverse effects including nephrotoxicity, hepatotoxicity, QT prolongation, and severe hypersensitivity

  • Describe regulatory and professional practice expectations relevant to antimicrobial use and stewardship accountability

Your checkpoint

A special-population dosing reference card covering at least eight agents across renal replacement, pregnancy, and pediatric categories

Week 7

Microbiology, Pathophysiology, and Immunology of Infectious Diseases & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents & Clinical Management of Infectious Diseases Syndromes

  • Synthesize microbiology, pharmacology, and clinical management into integrated management plans for unfamiliar organisms

  • Explain resistance mechanisms (ESBL, carbapenemase, MRSA, VRE) and match each to appropriate therapeutic alternatives

  • Review and correct weak areas identified in prior weeks using a personal error log

  • Complete a timed 60-question mixed-domain practice set under exam conditions

  • Analyze every missed practice question and classify the error as knowledge, interpretation, or reasoning

Your checkpoint

A categorized error log from the 60-question practice set with a remediation action for each error category

Week 8

Antimicrobial Stewardship and Infection Prevention & Clinical Management of Infectious Diseases Syndromes & Special Populations and Antimicrobial Dosing Considerations & Diagnostic Testing, Susceptibility Interpretation, and Therapeutic Drug Monitoring & Patient Safety, Adverse Effects, Drug Interactions, and Regulatory/Professional Practice

  • Rehearse rapid decision-making across all domains with two additional timed practice sets

  • Recite from memory the top 25 high-yield facts spanning PK/PD, stewardship metrics, and syndrome-specific therapy

  • Review the error log and confirm closure of every prior knowledge gap

  • Practice explaining stewardship and safety rationale aloud to simulate case-based reasoning

  • Finalize a one-page pre-exam summary sheet limited to the highest-yield content

Your checkpoint

A one-page high-yield summary sheet plus documented closure of at least 90% of error-log items

Milestones

Week 2: Score at least 90% on the PK calculation worksheet and correctly match all 12 antimicrobial classes to their PK/PD driver without notes

Week 4: Produce a complete stewardship intervention proposal with defined metrics and correctly interpret an antibiogram to justify three empiric regimen choices

Week 6: Demonstrate correct dosing adjustments for at least six of eight agents on the special-population card and identify all major drug interactions in a polypharmacy scenario

Week 7: Score at least 70% on the timed 60-question mixed-domain practice set and show a fully categorized error log

Week 8: Score at least 80% on the final timed practice set and document closure of at least 90% of error-log items